Fig. 3: Kaplan-Meier curves for the composite endpoint of intubation or death among patients with psychiatric disorders hospitalized for severe COVID-19 and receiving a FIASMA versus a non-FIASMA antidepressant at baseline. | Translational Psychiatry

Fig. 3: Kaplan-Meier curves for the composite endpoint of intubation or death among patients with psychiatric disorders hospitalized for severe COVID-19 and receiving a FIASMA versus a non-FIASMA antidepressant at baseline.

From: Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study

Fig. 3

Kaplan–Meier curves for the composite endpoint of intubation or death in the full sample crude analysis (N = 238) (A), in the full sample analysis with IPW (N = 238) (B), and in the matched analytic sample using a 1:1 ratio (N = 180) (C) among patients with psychiatric disorders hospitalized for severe COVID-19 and receiving a FIASMA versus a non-FIASMA antidepressant at baseline.

Back to article page